SC 13G/A: Autolus Therapeutics plc
Ticker: AUTL · Form: SC 13G/A · Filed: 2024-11-14T00:00:00.000Z
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by Autolus Therapeutics plc.
Risk Assessment
Risk Level: low
From the Filing
0001193125-24-258350.txt : 20241114 0001193125-24-258350.hdr.sgml : 20241114 20241114134427 ACCESSION NUMBER: 0001193125-24-258350 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20241114 DATE AS OF CHANGE: 20241114 GROUP MEMBERS: CHRISTOPHER HOLLOWOOD GROUP MEMBERS: ROEL BULTHUIS GROUP MEMBERS: SYNCONA HOLDINGS LTD GROUP MEMBERS: SYNCONA INVESTMENT MANAGEMENT LTD GROUP MEMBERS: SYNCONA LTD SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Autolus Therapeutics plc CENTRAL INDEX KEY: 0001730463 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-90550 FILM NUMBER: 241460048 BUSINESS ADDRESS: STREET 1: THE MEDIAWORKS STREET 2: 191 WOOD LANE CITY: LONDON STATE: X0 ZIP: W12 7FP BUSINESS PHONE: 44 20 3829 6230 MAIL ADDRESS: STREET 1: THE MEDIAWORKS STREET 2: 191 WOOD LANE CITY: LONDON STATE: X0 ZIP: W12 7FP FORMER COMPANY: FORMER CONFORMED NAME: Autolus Therapeutics Ltd DATE OF NAME CHANGE: 20180205 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Syncona Portfolio Ltd CENTRAL INDEX KEY: 0001725042 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: Y7 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 3RD FLOOR, ARNOLD HOUSE STREET 2: PO BOX 273, ST JULIAN'S AVENUE CITY: ST PETER PORT STATE: Y7 ZIP: GY1 3RD BUSINESS PHONE: 001442039817909 MAIL ADDRESS: STREET 1: FRANCES HOUSE, PO BOX 273 STREET 2: SIR WILLIAM PLACE CITY: ST PETER PORT, GUERNSEY STATE: X0 ZIP: GY1 3 RD SC 13G/A 1 d901415dsc13ga.htm SC 13G/A SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 7)* Autolus Therapeutics plc (Name of Issuer) American Depositary Shares and Ordinary Shares, nominal value $0.000042 per share (Title of Class of Securities) 05280R 100** (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☐ Rule 13d-1(b) ☐ Rule 13d-1(c) ☒ Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes ). ** There is no CUSIP number assigned to the ordinary shares. CUSIP number 05280R 100 has been assigned to the American Depositary Shares of the Issuer, which are quoted on the Nasdaq Global Select Market under the symbol “AUTL.” Each American Depositary Share represents the right to receive one ordinary share. SCHEDULE 13G/A CUSIP No. 05280R 100  1   Names of Reporting Person:  Syncona Portfolio Limited  2  Check the appropriate box if a member of a Group (see instructions)  (a) ☐  (b) ☒  3  SEC Use Only  4  Citizenship or Place of Organization  Guernsey Number of Shares  Beneficially  Owned by Each Reporting Person With: 5   Sole Voting Power  0 6  Shared Voting Power  30,734,957 (1) 7  Sole Dispositive Power  0 8  Shared Dispositive Power  30,734,957 (1)  9   Aggregate Amount Beneficially Owned by Each Reporting Person  30,734,957 (1) 10  Check box if